Bausch Health Companies | VRX - Aktuelle Verpflichtungen

Aktienkurs
6.83
Täglich Wechseln
-0.20 -2.78%
Monatlich
-18.46%
Jährlich
-31.75%
Q1 Prognose
6.73




Aktuelle Verpflichtungen Veränderung Datum
Amgen USD 25.49B 3.7B 2025-12
ANI Pharmaceuticals USD 278.11M 7.56M 2025-12
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Bausch Health Companies USD 4.18B 613M 2025-12
Biogen USD 3.35B 59.4M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Canopy Growth CAD 98.29M 17.19M 2025-12
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Danaher USD 6.81B 483M 2025-12
Drreddys Laboratories INR 1.76B 62.5M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Novo Nordisk DKK 215.66B 18.7B 2025-12
Pacira USD 120.59M 13.51M 2025-12
Perrigo USD 1.01B 132.4M 2025-12
Phibro Animal Health USD 282.37M 12.23M 2025-12
Prestige Brands USD 139.56M 4.95M 2025-12
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Zoetis USD 2.24B 428M 2025-12